At the time of writing, Actinium Pharmaceuticals Inc [ATNM] stock is trading at $8.31, up 21.14%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ATNM shares have gain 30.46% over the last week, with a monthly amount glided 58.59%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 26, February 2024, Actinium Announces Iomab-B Markedly Increases Long Term Survival in Patients 65 Years or Older with Active Relapsed or Refractory AML in the Phase 3 SIERRA Trial at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®. In a post published today on Yahoo Finance, – Active relapsed or refractory AML patients 65+ years receiving an Iomab-B led Bone Marrow Transplant (BMT) achieved significant improvement in survival at one and two years compared to control arm patients none of whom survived even one year.
From an analyst’s perspective:
Actinium Pharmaceuticals Inc [AMEX: ATNM] stock has seen the most recent analyst activity on September 06, 2023, when HSBC Securities initiated its Buy rating and assigned the stock a price target of $11.60. Previously, William Blair downgraded its rating to Mkt Perform on February 21, 2023. On September 08, 2022, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $20 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $16 on August 25, 2022. Alliance Global Partners initiated its recommendation with a Buy and recommended $25 as its price target on November 05, 2020. B. Riley FBR Inc. started tracking with a Buy rating for this stock on December 06, 2017, and assigned it a price target of $2.75.
For the past year, the stock price of Actinium Pharmaceuticals Inc fluctuated between $4.00 and $10.46. Actinium Pharmaceuticals Inc [AMEX: ATNM] shares were valued at $8.31 at the most recent close of the market.
Analyzing the ATNM fundamentals
According to Actinium Pharmaceuticals Inc [AMEX:ATNM], the company’s sales were 0.00M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.38 points at the first support level, and at 6.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.82, and for the 2nd resistance point, it is at 9.33.
Actinium Pharmaceuticals Inc [ATNM] reported earnings per share of -$0.49 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.53/share, meaning a difference of $0.04 and a surprise factor of 7.50%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.58 per share as compared to estimates of -$0.48 per share, a difference of -$0.1 representing a surprise of -20.80%.
Ratios To Look Out For
It is important to note that Actinium Pharmaceuticals Inc [AMEX:ATNM] has a current ratio of 9.87. In addition, the Quick Ratio stands at 9.87 and the Cash Ratio stands at 0.05.
